Refine by
Breast Positioning Suppliers & Manufacturers
5 companies found
based inHelsinki, FINLAND
The Finnish Planmed Oy dedicates its effort to the development, manufacturing and marketing of advanced imaging equipment and accessories that provide a unique combination of image quality and ease of use for medical imaging professionals. The ...
Planmed Clarity 2D is a comprehensive digital mammography system. The durable unit can be used for screening, diagnostic examinations, and stereotactic biopsies. Planmed Clarity 2D system comprises all the features of the Planmed Clarity™ ...
based inScandicci (Firenze), ITALY
Italray is an italian company that designs, manufactures and sells digital x-ray systems all over the world. Italray has been combining innovation and tradition since 1974 to offer its customers a wide range of reliable and competitive 100 MADE IN ...
The perfect synthesis between excellent imaging technology and successful design made of modern and ergonomic lines: the new Italray MAMMOGRAPH product line represents the ideal solution to satisfy every diagnostic request for clinical mammography: ...
based inHouston, TEXAS (USA)
Greenwich LifeSciences, Inc. (Nasdaq: GLSI) is a public biopharmaceutical company based in the Houston, TX area that is developing GP2, a novel peptide immunotherapy, and has commenced a Phase III clinical trial, called Flamingo-01. GP2 is derived ...
based inSeocho-gu, SOUTH KOREA
DK Medical Systems, located in SeoulKorea, is a medical equipment manufacturing company which specializes on the diagnostics radiology systems and imaging technology. More than 25 years, we have been working in radiology industry very closely with ...
ELMA-T3 is High Frequency Inverter Typeì˜ Mammography X-Ray ...
based inShanghai, CHINA
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune diseases and ophthalmic diseases. Up to date, 5 ...
(trastuzumab, Zercepac in the EU) was successfully launched in China and Europe, becoming the first Chinese mAb biosimilar entering both the EU and China market. It is indicated for the treatment of HER2 positive early ...